Previous research has showed that APS can inhibit lipid metabolism via miR-138-5p/SIRT1/SREBP1 pathways in prostate cancer [28] and improve lipid metabolism disorders in diabetic hamsters [29]. Here, SREBF1 is linked to prostate carcinoma.